Table 1.
MMR Schedule ¶ | 2019 | 2020 | 2021 | 2022 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
First Dose Age, mos | Second Dose Age, mos | Coverage, % | No. of Measles Cases ** (Incidence) § |
Coverage, % | No. of Measles Cases ** (Incidence) § |
Coverage, % | No. of Measles Cases ** (Incidence) § |
Coverage, % | No. of Measles Cases ** (Incidence) § |
|||||
Member States | MMR1 | MMR2 | MMR1 | MMR2 | MMR1 | MMR2 | MMR1 | MMR2 | ||||||
The Americas | 87 | 75 | 24,079 ** (17.7) | 87 | 65 | 8321 (6.07) | 85 | 68 | 724 ** (0.53) | 85 | 71 | 168 (0.12) | ||
North America | 90 | 94 | 1387 (3.78) | 91 | 83 | 14 (0.04) | 92 | 83 | 49 (0.13) | 92 | 79 | 124 (0.33) | ||
Canada | 12 | 90 | 87 | 113 (3.02) | 90 | 83 | 1 (0.03) | 90 | 83 | 0 (0) | 92 | 79 | 3 (0.08) | |
United States | 12 | 48 | 90 | 95 | 1274 (3.87) | 91 | 13 (0.04) | 92 | 49 (0.15) | 92 | 121 (0.36) | |||
Mexico | 12 | 18–72 | 73 | 73 | 20 (0.16) | 100 †† | 83 | 196 (1.52) | 100 †† | 97 | 0 (0) | 86 | 83 | 0 (0) |
Central America | 91 | 86 | 10 (0.2) | 86 | 79 | 0 (0) | 86 | 75 | 0 (0) | 83 | 73 | 0 (0) | ||
Costa Rica | 15 | 48 | 95 | 100 | 10 (1.98) | 95 | 81 | 0 (0) | 89 | 69 | 0 (0) | 90 | 75 | 0 (0) |
Guatemala | 12 | 18 | 90 | 78 | 0 (0) | 88 | 79 | 0 (0) | 81 | 72 | 0 (0) | 83 | 69 | 0 (0) |
El Salvador | 12 | 15–18 | 82 | 87 | 0 (0) | 71 | 56 | 0 (0) | 85 | 70 | 0 (0) | 65 | 59 | 0 (0) |
Honduras | 12 | 18 | 89 | 85 | 0 (0) | 82 | 79 | 0 (0) | 81 | 75 | 0 (0) | 77 | 71 | 0 (0) |
Nicaragua | 12 | 18 | 100 †† | 100 | 0 (0) | 100 †† | 100 †† | 0 (0) | 100 | 86 | 0 (0) | 100 †† | 100 †† | 0 (0) |
Panama | 12 ¶ | 18 ¶ | 97 | 97 | 0 (0) | 80 | 74 | 0 (0) | 92 | 75 | 0 (0) | 87 | 75 | 0 (0) |
Latin Caribbean | 85 | 59 | 1 (0.03) | 86 | 59 | 0 (0) | 83 | 60 | 0 (0.13) | 89 | 71 | 0 (0) | ||
Cuba | 12 | 72 | 100 | 100 | 1 (0.09) | 98 | 99 | 0 (0) | 100 | 100 | 0 (0) | 100 | 100 | 0 (0) |
Dominican Republic | 12 | 18 | 96 | 60 | 0 (0) | 82 | 55 | 0 (0) | 88 | 60 | 0 (0) | 100 †† | 87 | 0 (0) |
Haiti | 9 * | 12–23 * | 70 | 41 | 0 (0) | 83 | 46 | 0 (0) | 73 | 44 | 0 (0) | 76 | 46 | 0 (0) |
Andean | 89 | 62 | 802 (5.72) | 82 | 61 | 3 (0.02) | 77 | 63 | 0 (0) | 79 | 66 | 0 (0) | ||
Bolivia (Plurinational State of) | 12 | 18–23 | 79 | 44 | 0 (0) | 74 | 46 | 2 (0.17) | 75 | 56 | 0 (0) | 69 | 49 | 0 (0) |
Colombia | 12 | 60 | 95 | 89 | 252 (5.01) | 91 | 88 | 1 (0.02) | 86 | 86 | 0 (0) | 88 | 84 | 0 (0) |
Ecuador | 12 | 18 | 83 | 76 | 0 (0) | 81 | 70 | 0 (0) | 65 | 58 | 0 (0) | 74 | 60 | 0 (0) |
Peru | 12 | 18 | 85 | 66 | 2 (0.06) | 77 | 52 | 0 (0) | 78 | 60 | 0 (0) | 74 | 54 | 0 (0) |
Venezuela (Bolivarian Republic of) | 12 ¶ | 18 ¶ | 93 | 13 | 548 (19.22) | 76 | 28 | 0 (0) | 68 | 38 | 0 (0) | 0 (0) | ||
Brazil | 12 | 91 | 54 | 21,704 (102.84) | 80 | 44 | 8035 (37.8) | 73 | 46 | 670 (3.13) | 81 | 58 | 41 (0.19) | |
Southern Cone | 87 | 84 | 150 (2.02) | 79 | 73 | 73 (0.97) | 84 | 79 | 0 (0) | 82 | 84 | 3 (0.04) | ||
Argentina | 12 | 60 | 86 | 84 | 130 (2.9) | 77 | 71 | 69 (1.53) | 86 | 79 | 0 (0) | 85 | 94 | 2 (0.04) |
Chile | 12 | 36 | 95 | 91 | 11 (0.58) | 91 | 83 | 2 (0.1) | 92 | 91 | 0 (0) | 94 | 81 | 0 (0) |
Paraguay | 12 | 48 | 75 | 71 | 0 (0) | 68 | 60 | 0 (0) | 56 | 55 | 0 (0) | 42 | 41 | 1 (0.15) |
Uruguay | 12 | 15 | 96 | 99 | 9 (2.6) | 96 | 92 | 2 (0.58) | 93 | 82 | 0 (0) | 96 | 92 | 0 (0) |
non-Latin Caribbean | 94 | 87 | 4 (0.63) | 90 | 84 | 0 (0) | 87 | 80 | 0 (0) | 91 | 84 | 0 (0) | ||
Antigua and Barbuda | 12 | 18 | 97 | 71 | 0 (0) | 89 | 80 | 0 (0) | 85 | 76 | 0 (0) | 100 | 100 | 0 (0) |
Bahamas | 12 | 15 | 83 | 83 | 3 (7.7) | 87 | 83 | 0 (0) | 82 | 80 | 0 (0) | 80 | 65 | 0 (0) |
Belize | 12 | 18 | 96 | 95 | 0 (0) | 82 | 87 | 0 (0) | 79 | 77 | 0 (0) | 81 | 77 | 0 (0) |
Barbados | 100 †† | 85 | 0 (0) | 89 | 78 | 0 (0) | 77 | 70 | 0 (0) | 85 | 73 | 0 (0) | ||
Dominica | 12 | 18 | 92 | 92 | 0 (0) | 92 | 90 | 0 (0) | 88 | 87 | 0 (0) | 87 | 87 | 0 (0) |
Grenada | 12 | 18 | 94 | 82 | 0 (0) | 83 | 79 | 0 (0) | 70 | 55 | 0 (0) | 76 | 68 | 0 (0) |
Guyana | 12 | 18 | 98 | 92 | 0 (0) | 100 †† | 97 | 0 (0) | 95 | 83 | 0 (0) | 100 †† | 100 †† | 0 (0) |
Jamaica | 12 | 18 | 94 | 92 | 0 (0) | 93 | 89 | 0 (0) | 88 | 85 | 0 (0) | 91 | 83 | 0 (0) |
Saint Kitts and Nevis | 12 | 18 | 97 | 98 | 0 (0) | 95 | 99 | 0 (0) | 96 | 94 | 0 (0) | 95 | 93 | 0 (0) |
Saint Lucia | 12 | 18 | 96 | 75 | 1 (5.47) | 89 | 72 | 0 (0) | 77 | 66 | 0 (0) | 81 | 63 | 0 (0) |
Saint Vincent and the Grenadines | 12 | 18 | 100 †† | 100 †† | 0 (0) | 100 †† | 100 †† | 0 (0) | 96 | 94 | 0 (0) | 99 | 100 | 0 (0) |
Suriname | 12 | 18 | 85 | 43 | 0 (0) | 66 | 35 | 0 (0) | 79 | 58 | 0 (0) | 95 | 65 | 0 (0) |
Trinidad and Tobago | 12 | 24 | 99 | 92 | 0 (0) | 91 | 90 | 0 (0) | 93 | 88 | 0 (0) | 92 | 92 | 0 (0) |
Abbreviations: MMR = measles-mumps and rubella vaccine; MMR1 = first MMR dose; MMR2 = second MMR dose; NA = not applicable; NR = not reported; WHO = World Health Organization. * According to OFFICIAL coverage reported. For MMR1, among children aged 1 year or, if MMR is given at age ≥1 year, among children aged 24 months. For MMR2, among children at the recommended age for administration of MMR2, per the national immunization schedule. Haiti administers MR vaccine. The data were last revised on 15 July 2023 at https://immunizationdata.who.int. ** Includes cases confirmed by laboratory testing or epidemiologic linkage and clinically compatible cases. Clinically compatible cases met the WHO measles clinical case definition, had no adequate specimen collected, and could not be epidemiologically linked to a laboratory-confirmed case of measles. Case totals based on country reports to CIM-PAHO weekly surveillance reports. WHO Non-member states Curaçao and French Guiana reported measles cases, 1 (2019) and 5 (2022) respectively. § Cases per 1 million population. ¶ MMR schedule is the 2022 schedule; Panama and Venezuela schedule from 2021. †† coverage data >100%. The data of each subregion have been bolded to highlight the average of all countries belonging to that subregion.